Anti PCSK9 Monoclonal Antibody Treatment in Elderly Patients: A Real-world Clinical Experience

CONCLUSIONS: PCSK9 mAbs have similar effects and are well tolerated among elderly patients as in younger patients.PMID:38420988

Source: The Israel Medical Association Journal - February 29, 2024 Category: General Medicine Authors: Ela Giladi Roy Israel Wasseem Daud Chen Gurevitz Alaa Atamna David Pereg Abid Assali Avishay Elis Source Type: research